InsidersTradesSigma
Follow the China Pharma Holdings, INC. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, China Pharma Holdings, INC. has recorded 2 reports. Market capitalisation: €328.2m. The latest transaction was disclosed on 19 October 2023 (Attribution). Among the most active insiders: Li Zhilin. The full history is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,952 of 28,753 companies
17.4
score / 100
Value29
Quality6
FCF yld0.0%
Earn yld-7.2%
EV/EBITDA·
ROE-16%
Gross mgn-3.2%
Net mgn-77%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 October 2023
About China Pharma Holdings, INC.
China Pharma Holdings, INC. is a company focused on the health and pharmaceutical sector. It is listed on NASDAQ under the ticker XNAS.
